Prothena Corporation PLC (PRTA) Cotización

PRTA basing since April

for save some unrelated infor.

The Weekly is due for a correction.

Next week a new Weekly high is possible.

Based on average Weekly W-SC-2 phases, a W-S-1 (Bear phase) is due 4/16/21

The high was due this week.

I'm looking at a drop to W-S-1(Overdue) 3766.83, W-1 (Extreme Overdue) 3672.18, W-E-1 (Overdue) 3075.34, W-SC-1 (Record breaking Extreme Overdue) 2427.33

At this point I would say the W-1 is the most likely during this next Weekly Bear Cycle.

The W-1 normally lasts 4 weeks and usually puts in a low by the 3rd week.

UP OVER 8% TODAY

COULD BREAK $30

BREAKING NEWS: $PRTA Prothena Reports Third Quarter 2020 Financial Results and Provides R&D Update

Net cash used in operating and investing activities was $19.5 million in the third quarter and $61.4 million for the first nine months of 2020; quarter-end cash and restricted cash position of $317.2 million provides funding to advance the R&D pipeline Roche presente...

Got this from PRTA - Prothena Reports Third Quarter 2020 Financial Results and Provides R&D Update

JUST IN: $PRTA Prothena Announces Presentations on Two Programs from its Alzheimer's Disease Portfolio at CTAD 2020

Next generation anti- Aβ antibod ies being developed for subcutaneous administration to improve access for patient s with Alzheimer’s disease Multi- i mmunogen Aβ- t au va ccine ...

Find out more PRTA - Prothena Announces Presentations on Two Programs from its Alzheimer's Disease Portfolio at CTAD 2020

See what kind of reaction we get Today

* * $PRTA Video Chart 12-20-2019 * *

Link to Video - click here to watch the technical chart video

Looks like more profit taking

Nice bouncer this PRTA! Took it from 10.98 yesterday!

No need to force a trade. if $10 drops I'll look then

Now the Question: What's it worth. Is this a dip buy or the start of a slow further fall first; before it eventually has a bit of a pop>?

Dodged a bullet.. had to check a few different accounts to makes sure I didn't take a hit here.

$PRTA - Prothena Announces Global Neuroscience Research & Development Collaboration with Celgene for Novel Therapies for Patients with Neurodegenerative Diseases

https://www.nasdaq.com/press-release/prothena-announces-global-neuroscience-research--development-collaboration-with-celgene-for-novel-20180320-01160

Always belonged in the $40s...

Cantor Fitz buy rating yesterday.

Jefferies sticking with $100

move into the $40s not unreasonable over next couple weeks.

https://transcriptdaily.com/2017/12/21/prothena-prta-given-buy-rating-at-cantor-fitzgerald.html

Long Slide and Price Targets double from here, this is often a good time to dip toes in water, IMO.

want to see $35 hold

https://stocknewstimes.com/2017/12/21/prothena-prta-given-a-70-00-price-target-by-oppenheimer-analysts.html

Still trying to form a base but belongs in $40s right here

bought in $36.63

Prothena Corp $PRTA valuation models imply nice upside b4 earnings Tuesday...

Fair Value Analysis

fast and steady profit scan PRTA bullish 59.97



normal chart


log chart

$PRTA recent news/filings

bullish optionable 68.37

## source: finance.yahoo.com

Tue, 15 Dec 2015 21:14:05 GMT ~ PROTHENA CORP PLC Files SEC form 8-K, Change in Directors or Principal Officers


read full: http://biz.yahoo.com/e/151215/prta8-k.html
*********************************************************

Sat, 12 Dec 2015 14:09:00 GMT ~ 3 Rising Biotechs That Should Continue Their Upward Trends


read full: http://www.thestreet.com/story/13395241/1/3-rising-biotechs-that-should-continue-their-upward-trends.html?puc=yahoo&cm_ven=YAHOO
*********************************************************

Tue, 08 Dec 2015 18:16:55 GMT ~ PROTHENA CORP PLC Financials


read full: http://finance.yahoo.com/q/is?s=prta
*********************************************************

Mon, 07 Dec 2015 20:45:31 GMT ~ How Are IBB’s American Depositary Receipts Performing?


read full: http://finance.yahoo.com/news/ibb-american-depositary-receipts-performing-204531984.html
*********************************************************

Wed, 02 Dec 2015 23:13:53 GMT ~ Here is What Hedge Funds Think About Prothena Corporation PLC (PRTA)


read full: http://www.insidermonkey.com/blog/here-is-what-hedge-funds-think-about-prothena-corporation-plc-prta-398667/
*********************************************************

$PRTA charts

basic chart ## source: stockcharts.com



basic chart ## source: stockscores.com



big daily chart ## source: stockcharts.com



big weekly chart ## source: stockcharts.com



$PRTA company information

## source: otcmarkets.com

Link: http://www.otcmarkets.com/stock/PRTA/company-info
Ticker: $PRTA
OTC Market Place: Not Available
CIK code: not found
Company name: Prothena Corp plc
Incorporated In:

Business Description:

$PRTA share structure

## source: otcmarkets.com

Market Value: Not Available
Shares Outstanding: Not Available
Float: Not Available
Authorized Shares: Not Available
Par Value: Not Available

$PRTA extra dd links

Company name: Prothena Corp plc
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/PRTA/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/PRTA/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=PRTA+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=PRTA+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=PRTA+Industry

## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/PRTA/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/PRTA/news - http://finance.yahoo.com/q/h?s=PRTA+Headlines

## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/PRTA/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/PRTA/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/PRTA/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/PRTA/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/PRTA/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/PRTA/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/PRTA/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/PRTA/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=PRTA+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/PRTA
DTCC (dtcc.com): http://search2.dtcc.com/?q=Prothena+Corp+plc&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Prothena+Corp+plc
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Prothena+Corp+plc&x=0&y=0

## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/PRTA/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/PRTA
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/PRTA/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/PRTA/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/PRTA/sec-filings
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/PRTA/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/PRTA/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/PRTA/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/PRTA/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=PRTA&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=PRTA
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/PRTA/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=PRTA+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=PRTA+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=PRTA
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=PRTA
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=PRTA+Cash+Flow&annual

## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/PRTA/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=PRTA+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/PRTA.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=PRTA
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/PRTA/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/PRTA/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/PRTA/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/PRTA/insider-transactions

## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/PRTA
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/PRTA
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/PRTA:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=PRTA
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=PRTA



$PRTA DD Notes ~ http://www.ddnotesmaker.com/PRTA

PRX002 - Excellent single dose results released today

Conference call at 5:30 PM EDT. See link below for further details.

Enjoy dp


http://finance.yahoo.com/news/prothena-presents-clinical-results-demonstrating-110000092.html


Prothena Presents Clinical Results Demonstrating Robust, Rapid Reduction in Levels of Free Serum Alpha-Synuclein of Up to 96% After Single Dose of PRX002, Novel Protein Immunotherapy for Parkinson's Disease

Prothena Corporation plc GlobeNewswire

PRX002 was Safe and Well Tolerated; Phase 1 Single Ascending Dose Study Objectives Met
Dose- and Time-Dependent, Statistically Significant Reduction in Free Serum Alpha-Synuclein within One Hour of PRX002 Administration
Data Presented in Late Breaking Poster Session at 19th International Congress of Parkinson's Disease and Movement Disorders (Abstract #LBA19) in San Diego
Investor Conference Call and Webcast Today at 5:30 p.m. EDT

$PRTA recent news/filings

bullish

## source: finance.yahoo.com

Fri, 29 May 2015 13:25:27 GMT ~ Prothena Shares Initiated With Buy At UBS


read full: http://finance.yahoo.com/news/prothena-shares-initiated-buy-ubs-132527070.html
*********************************************************

Tue, 26 May 2015 23:05:01 GMT ~ Lightning Round: Great spec for 2nd half of 2015


read full: http://www.cnbc.com/id/102707966?__source=yahoo%7cfinance%7cheadline%7cheadline%7cstory&par=yahoo&doc=102707966
*********************************************************

Fri, 22 May 2015 18:18:41 GMT ~ PROTHENA CORP PLC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders


read full: http://biz.yahoo.com/e/150522/prta8-k.html
*********************************************************

Thu, 21 May 2015 12:16:38 GMT ~ Prothena Announces Presentation of Clinical Data From the Ongoing Phase 1/2 NEOD001 Study and Systemic Amyloidosis Patient Survey Results at 20th Congress of the European Hematology Association

[at noodls] - DUBLIN, Ireland, May 21, 2015 (GLOBE NEWSWIRE) -- Prothena Corporation plc (Nasdaq:PRTA), a late-stage clinical biotechnology company focused on the discovery, development and commercialization of novel ...

read full: http://www.noodls.com/view/FC8F922DE1BB00D899DBCC30C082FDDDE8451D4A
*********************************************************

Thu, 21 May 2015 12:01:01 GMT ~ Prothena Announces Presentation of Clinical Data From the Ongoing Phase 1/2 NEOD001 Study and Systemic Amyloidosis Patient Survey Results at 20th Congress of the European Hematology Association

[GlobeNewswire] - DUBLIN, Ireland, May 21, 2015 (GLOBE NEWSWIRE) -- Prothena Corporation plc (Nasdaq:PRTA), a late-stage clinical biotechnology company focused on the discovery, development and commercialization of novel ...

read full: http://finance.yahoo.com/news/prothena-announces-presentation-clinical-data-120101865.html
*********************************************************

$PRTA charts

basic chart ## source: stockcharts.com



basic chart ## source: stockscores.com



big daily chart ## source: stockcharts.com



big weekly chart ## source: stockcharts.com



$PRTA company information

## source: otcmarkets.com

Link: http://www.otcmarkets.com/stock/PRTA/company-info
Ticker: $PRTA
OTC Market Place: Not Available
CIK code: not found
Company name: Prothena Corp plc
Incorporated In:

Business Description:

$PRTA share structure

## source: otcmarkets.com

Market Value: Not Available
Shares Outstanding: Not Available
Float: Not Available
Authorized Shares: Not Available
Par Value: Not Available

$PRTA extra dd links

Company name: Prothena Corp plc
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/PRTA/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/PRTA/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=PRTA+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=PRTA+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=PRTA+Industry

## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/PRTA/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/PRTA/news - http://finance.yahoo.com/q/h?s=PRTA+Headlines

## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/PRTA/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/PRTA/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/PRTA/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/PRTA/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/PRTA/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/PRTA/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/PRTA/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/PRTA/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=PRTA+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/PRTA
DTCC (dtcc.com): http://search2.dtcc.com/?q=Prothena+Corp+plc&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Prothena+Corp+plc
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Prothena+Corp+plc&x=0&y=0

## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/PRTA/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/PRTA
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/PRTA/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/PRTA/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/PRTA/sec-filings
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/PRTA/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/PRTA/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/PRTA/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/PRTA/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=PRTA&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=PRTA
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/PRTA/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=PRTA+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=PRTA+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=PRTA
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=PRTA
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=PRTA+Cash+Flow&annual

## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/PRTA/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=PRTA+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/PRTA.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=PRTA
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/PRTA/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/PRTA/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/PRTA/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/PRTA/insider-transactions

## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/PRTA
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/PRTA
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/PRTA:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=PRTA
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=PRTA



$PRTA DD Notes ~ http://www.ddnotesmaker.com/PRTA

Prothena Announces Pricing of Public Offering of 3,300,000 Ordinary Shares

Source: GlobeNewswire Inc.

Prothena Corporation plc (Nasdaq:PRTA), a late-stage clinical biotechnology company focused on the discovery, development and commercialization of novel protein immunotherapy programs, announced today that it priced an underwritten public offering of 3,300,000 of its ordinary shares at a price to the public of $37.00 per ordinary share, before the underwriting discount. All of the ordinary shares in the offering were sold by Prothena. In addition, Prothena has granted the underwriters a 30-day option to purchase up to an additional 495,000 of its ordinary shares.
Net proceeds to Prothena from the ordinary shares to be sold by Prothena in the offering are expected to be $114.2 million, after deducting the underwriting discount and estimated offering expenses, but excluding any exercise of the underwriters' option to purchase additional ordinary shares. The offering is expected to close on April 13, 2015, subject to customary closing conditions.

Credit Suisse, RBC Capital Markets and UBS Investment Bank are acting as joint book-running managers, and Oppenheimer & Co., Wedbush PacGrow, Ladenburg Thalmann and LifeSci Capital are acting as co-managers for the offering.

New paid pump out today in my email, the publisher was paid $5,000

Best of luck. All i know is im not losing any time soon lol. WHEN it hits $35.35 i'll cover take profits and be a bull lol :D

READ #61

Huge reversal today

Just make sure you're here when it makes its way back up to highs...

Been a DUKE fan forever. > also they have made the last 20 NCAA tournaments.

F Duke I hate them. I can't talk much my Hoyas are knocked out once again and my Nittany Lions didn't even make it. Kentucky takes the title...

Fantastic freshman players.... Okafor, Jones, Winslow!

DUKE!!! My whole family went to DUKE!! Blue Baby! BLUE! Lol

Glad you had fun! ... My DUKE team won! So much for PRTA!

Told you! BEARISH. Just saying. This weekend I had steak and potatoes and got tickets to the Kevin Hart show lol. If it keeps going down I may by you some Taco Bell bro

Yup! Looks like more profit taking.

$35 <MONDAY>

Yeah. Sounds really good. Crazy low float and 10% short although that prolly dropped a lot today.

CEO was on MAD MONEY!

Getting a pump by cramerica. This thing prolly gonna run next week.

Nice!

38.61 close. & up in AH!

Solid day here! I just added another 550 shares.

Oh is that why i'm counting my money? Lmfao I love being clueless. My short position is quite green hahaha and I'm holding through the weekend like a boss. I think i'm buy something special this weekend haha

Tutes, mutual funds, pensions, etc > BUYING !!!!!

I don't even pay them any mind. To each his own...

LMAO! Folks that are shorting are clueless and lost in the shuffle.

With HUGE sell volume and small buy volume youve got yourself a water fall. I wouldnt suggest buying unless you are going BIG!! 100k+ Big and thats only if you holding for the long lol

Lol Actually Ive always been a bull far from troll. I understand why youre made though from a bull perspective. Been there lol. I'd be upset if some idiot was shorting BIIB LOL